Discontinued — last reported Q4 '25
Investing
Business Sale Proceeds
Accenture Business Sale Proceeds decreased by 98.5% to $348.00K in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 96.6%, from $10.16M to $348.00K.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2014
Last reportedQ4 2025
How to read this metric
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
Detailed definition
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Peer comparison
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
Metric ID:
proceeds_from_sale_of_businessHistorical Data
12 periods
| Q1 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$314.00K | $596.00K | $17.28M | $400.24M | $0.00 | $20.91M | $0.00 | $5.27M | $10.16M | $7.32M | $22.63M | $348.00K |
| QoQ Change | — | +289.8% | >999% | >999% | -100.0% | — | -100.0% | — | +92.8% | -28.0% | +209.4% | -98.5% |
| YoY Change | — | — | — | — | -100.0% | +21.0% | -100.0% | — | -51.4% | — | +329.5% | -96.6% |
Range-$314.00K – $400.24M
CAGR+3.8%
Avg YoY Growth+0.4%
Median YoY Growth-74.0%
Business Sale Proceeds at Other Companies
Frequently Asked Questions
- What is Accenture's business sale proceeds?
- Accenture (ACN) reported business sale proceeds of $348.00K in Q4 2025.
- How has Accenture's business sale proceeds changed year-over-year?
- Accenture's business sale proceeds decreased by 96.6% year-over-year, from $10.16M to $348.00K.
- What does business sale proceeds mean?
- Cash received from selling off parts of the business.